rs56369086
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000135.4(FANCA):c.2101A>G(p.Lys701Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,614,190 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FANCA | NM_000135.4 | c.2101A>G | p.Lys701Glu | missense_variant | 23/43 | ENST00000389301.8 | |
FANCA | NM_001286167.3 | c.2101A>G | p.Lys701Glu | missense_variant | 23/43 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FANCA | ENST00000389301.8 | c.2101A>G | p.Lys701Glu | missense_variant | 23/43 | 1 | NM_000135.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000335 AC: 51AN: 152210Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000581 AC: 146AN: 251488Hom.: 3 AF XY: 0.000493 AC XY: 67AN XY: 135920
GnomAD4 exome AF: 0.000170 AC: 248AN: 1461862Hom.: 3 Cov.: 34 AF XY: 0.000150 AC XY: 109AN XY: 727226
GnomAD4 genome ? AF: 0.000335 AC: 51AN: 152328Hom.: 1 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74494
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Aug 12, 2021 | - - |
Fanconi anemia complementation group A Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 09, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2021 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Nov 03, 2022 | - - |
FANCA-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 04, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at